How Has The Computer Vision in Microbiome Market Size Evolved In Recent Years?
The microbiome market has seen considerable growth due to a variety of factors.
• In the past few years, the size of the microbiome market has seen an explosive growth. The market size is projected to increase from a value of $0.68 billion in 2024 to $0.82 billion in 2025, representing a compound annual growth rate (CAGR) of 20.1%.
Factors contributing to the historical growth of this sector include a rising demand in immunology, an uptick in collaborations, governmental initiatives, augmented healthcare spending, and an increase in the totals of healthcare facilities.
What is the Forecasted Market Size and CAGR for the Microbiome Market?
The microbiome market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the microbiome market is predicted to experience substantial expansion in the coming years, reaching $1.43 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%.
This predicted rise in the forecast window can be traced back to elements such as an increase in healthcare expenditure, an augmented need for personalized medicine, a boost in funding, technological advancements, and a surge in the incidence of chronic illnesses. The forecast period will likely see some key trends, including the application of artificial intelligence, strategic partnerships and agreements, revenue growth and the establishment of category leadership. It also includes an increase in pipeline investigations for the creation of microbiome therapeutics for diverse ailments, and potential investment in the production of oncology microbiome therapeutics to enhance the productivity, efficacy, and accuracy of precision technologies.
What Main Forces Are Fueling Expansion In The Microbiome Market?
The growth of the microbiome market is significantly influenced by the rising prevalence of inflammatory bowel disease (IBD). IBD comprises a series of chronic inflammatory conditions affecting the digestive tract, primarily the gastrointestinal (GI) tract. The link between IBD and the gut microbiome has been under extensive scrutiny, leading to an influx in research, diagnostic efforts, and therapeutic measures focused on the microbiome, thereby propelling the microbiome market's expansion. For example, as per the American Gastroenterological Association (AGA), a U.S. based association for gastroenterologists, uncomfortable bowel symptoms have forced 40% of Americans to suspend their daily activities as of September 2022. Additionally, 60-70 million Americans contend with disruptive gastrointestinal diseases. Hence, the upward trend in the occurrence of inflammatory bowel disease (IBD) is expected to fuel the growth of the microbiome market.
What Are The Principal Market Segments In The Global Microbiome Healthcare Industry?
The microbiome market covered in this report is segmented –
1) By Type: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
4) By Technology: Genomics, Proteomics, Metabolomics
3) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
Pre-Book The Microbiome Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Microbiome
The increasing advancement in technology is a prominent trend emerging in the microbiome market. Many influential companies in the microbiome industry are concentrating on generating advanced technological platforms for the study and manipulation of microbiomes. Seed, an upcoming firm in the microbiome realm, has launched Probiotic and Prebiotic Daily Synbiotic intended for use by both genders. The Daily Synbiotic from Seed is the pioneering product to adopt a microbe-system method, offering strain-specific benefits stretching beyond just digestive health and encompassing aspects like cardiac safety, skin health, immune regulation, reproductive health, gut barrier integrity and oxidative stress management.
Who Are the Key Players in the Microbiome Market?
Major companies operating in the microbiome market include:
• Seres Therapeutics
• Enterome Bioscience
• Ferring Pharmaceuticals
• Vedanta BioSciences
• Second Genome Inc.
• Microbiotica
• Rebiotix. Inc
• Locus Biosciences
• Osel Inc.
• Xbiome Co. Ltd
• Microba Life Sciences
• Biome Australia
• Shoreline Biome
• Leucine Rich Bio Pvt Ltd
• BugSpeaks
• KINS Co. Ltd
• Yeda Research and Development Co. Ltd
• China National Pharmaceutical Group Corporation
• Atlas Biomed
• BiomX Ltd
• ImmuneBiotech Medical Sweden AB
• MetaboGen AB
• ADM Biopolis
• Viome
• PharmaBiome
• NCCR Microbiomes
• MaaT Pharma
• Eligo Bioscience
• T3 Pharmaceuticals
• MicroBiome Therapeutics LLC
• OpenBiome
• Microbiome Insights Inc.
• Lallemand Health Solutions
• Mybiotics Pharma
• DayTwo
• Next Biosciences
• ViThera Pharmaceuticals Inc.
• Inqaba Biotechnical Industries (Pty)
• SNIPR Biome
• MyBiome
What are the Regional Insights into the Microbiome Market?
North America was the largest region in the microbiome market in 2024. The regions covered in the microbiome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
